Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 949

1.

The 2020 motile active matter roadmap.

Gompper G, Winkler RG, Speck T, Solon A, Nardini C, Peruani F, Löwen H, Golestanian R, Kaupp UB, Alvarez L, Kiørboe T, Lauga E, Poon WCK, DeSimone A, Muiños-Landin S, Fischer A, Söker NA, Cichos F, Kapral R, Gaspard P, Ripoll M, Sagues F, Doostmohammadi A, Yeomans JM, Aranson IS, Bechinger C, Stark H, Hemelrijk CK, Nedelec FJ, Sarkar T, Aryaksama T, Lacroix M, Duclos G, Yashunsky V, Silberzan P, Arroyo M, Kale S.

J Phys Condens Matter. 2020 Feb 14;32(19):193001. doi: 10.1088/1361-648X/ab6348. [Epub ahead of print]

PMID:
32058979
2.

Experimental models for discovery of novel anticonvulsant drugs: Focus on Pentylenetetrazole-induced seizures and associated memory deficits.

Alachkar A, Ojha SK, Sadeq A, Adem A, Frank A, Stark H, Sadek B.

Curr Pharm Des. 2020 Jan 30. doi: 10.2174/1381612826666200131105324. [Epub ahead of print]

PMID:
32003682
3.

Surfactant assisted extraction of incidental nanoparticles from road runoff sediment and their characterization by single particle-ICP-MS.

Baur S, Reemtsma T, Stärk HJ, Wagner S.

Chemosphere. 2019 Dec 28;246:125765. doi: 10.1016/j.chemosphere.2019.125765. [Epub ahead of print]

PMID:
31927370
4.

4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibition.

Smelcerovic A, Zivkovic A, Ilic BS, Kolarevic A, Hofmann B, Steinhilber D, Stark H.

Bioorg Chem. 2020 Jan;95:103528. doi: 10.1016/j.bioorg.2019.103528. Epub 2019 Dec 20.

PMID:
31918397
5.

Fiber laser-driven gas plasma-based generation of THz radiation with 50-mW average power.

Buldt J, Mueller M, Stark H, Jauregui C, Limpert J.

Appl Phys B. 2020;126(1):2. doi: 10.1007/s00340-019-7353-2. Epub 2019 Nov 26.

6.

Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases.

Ackermann M, Stark H, Neubert L, Schubert S, Borchert P, Linz F, Wagner WL, Stiller W, Wielpütz M, Hoefer A, Haverich A, Mentzer SJ, Shah HR, Welte T, Kuehnel M, Jonigk D.

Eur Respir J. 2019 Dec 5. pii: 1900933. doi: 10.1183/13993003.00933-2019. [Epub ahead of print]

PMID:
31806721
7.

Linear and angular motion of self-diffusiophoretic Janus particles.

Burelbach J, Stark H.

Phys Rev E. 2019 Oct;100(4-1):042612. doi: 10.1103/PhysRevE.100.042612.

PMID:
31771000
8.

23  mJ high-power fiber CPA system using electro-optically controlled divided-pulse amplification.

Stark H, Buldt J, Müller M, Klenke A, Tünnermann A, Limpert J.

Opt Lett. 2019 Nov 15;44(22):5529-5532. doi: 10.1364/OL.44.005529.

PMID:
31730100
9.

Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands.

Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B.

Eur J Med Chem. 2020 Jan 1;185:111785. doi: 10.1016/j.ejmech.2019.111785. Epub 2019 Oct 17.

PMID:
31669851
10.

In silico and in vitro studies of two non-imidazole multiple targeting agents at histamine H3 receptors and cholinesterase enzymes.

Ghamari N, Dastmalchi S, Zarei O, Arias-Montaño JA, Reiner D, Ustun-Alkan F, Stark H, Hamzeh-Mivehroud M.

Chem Biol Drug Des. 2020 Feb;95(2):279-290. doi: 10.1111/cbdd.13642. Epub 2019 Nov 12.

PMID:
31661597
11.

Budgets of Organic Carbon Composition and Oxidation in Indoor Air.

Price DJ, Day DA, Pagonis D, Stark H, Algrim LB, Handschy AV, Liu S, Krechmer JE, Miller SL, Hunter JF, de Gouw JA, Ziemann PJ, Jimenez JL.

Environ Sci Technol. 2019 Nov 19;53(22):13053-13063. doi: 10.1021/acs.est.9b04689. Epub 2019 Nov 8.

PMID:
31652057
12.

Prior Activation of 5-HT7 Receptors Modulates the Conditioned Place Preference With Methylphenidate.

Carbone C, Lo Russo SLM, Lacivita E, Frank A, Alleva E, Stark H, Saso L, Leopoldo M, Adriani W.

Front Behav Neurosci. 2019 Sep 18;13:208. doi: 10.3389/fnbeh.2019.00208. eCollection 2019.

13.

Determination of scoring functions for protein damage susceptibility.

Fichtner M, Schuster S, Stark H.

Biosystems. 2020 Jan;187:104035. doi: 10.1016/j.biosystems.2019.104035. Epub 2019 Oct 12.

PMID:
31614190
14.

Small-molecule inhibitors of nisin resistance protein NSR from the human pathogen Streptococcus agalactiae.

Porta N, Zaschke-Kriesche J, Frieg B, Gopalswamy M, Zivkovic A, Etzkorn M, Stark H, Smits SHJ, Gohlke H.

Bioorg Med Chem. 2019 Oct 15;27(20):115079. doi: 10.1016/j.bmc.2019.115079. Epub 2019 Aug 26.

PMID:
31500943
15.

Translational techniques from cleft to cosmetic rhinoplasty.

Stark HL, Fries CA, Mercer NS.

Arch Plast Surg. 2020 Jan;47(1):110-113. doi: 10.5999/aps.2018.00185. Epub 2019 Aug 30. No abstract available.

16.

Morphological and molecular motifs of fibrosing pulmonary injury patterns.

Jonigk D, Stark H, Braubach P, Neubert L, Shin HO, Izykowski N, Welte T, Janciauskiene S, Warnecke G, Haverich A, Kuehnel M, Laenger F.

J Pathol Clin Res. 2019 Oct;5(4):256-271. doi: 10.1002/cjp2.141. Epub 2019 Sep 25.

17.

The class II benzoyl-coenzyme A reductase complex from the sulfate-reducing Desulfosarcina cetonica.

Anselmann SEL, Löffler C, Stärk HJ, Jehmlich N, von Bergen M, Brüls T, Boll M.

Environ Microbiol. 2019 Nov;21(11):4241-4252. doi: 10.1111/1462-2920.14784. Epub 2019 Sep 1.

PMID:
31430028
18.

Rasagiline derivatives combined with histamine H3 receptor properties.

Lutsenko K, Hagenow S, Affini A, Reiner D, Stark H.

Bioorg Med Chem Lett. 2019 Oct 1;29(19):126612. doi: 10.1016/j.bmcl.2019.08.016. Epub 2019 Aug 9.

PMID:
31421966
19.

The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice.

Eissa N, Azimullah S, Jayaprakash P, Jayaraj RL, Reiner D, Ojha SK, Beiram R, Stark H, Łażewska D, Kieć-Kononowicz K, Sadek B.

Chem Biol Interact. 2019 Oct 1;312:108775. doi: 10.1016/j.cbi.2019.108775. Epub 2019 Jul 30.

PMID:
31369746
20.

Structural modifications and in vitro pharmacological evaluation of 4-pyridyl-piperazine derivatives as an active and selective histamine H3 receptor ligands.

Szczepańska K, Karcz T, Siwek A, Kuder KJ, Latacz G, Bednarski M, Szafarz M, Hagenow S, Lubelska A, Olejarz-Maciej A, Sobolewski M, Mika K, Kotańska M, Stark H, Kieć-Kononowicz K.

Bioorg Chem. 2019 Oct;91:103071. doi: 10.1016/j.bioorg.2019.103071. Epub 2019 Jun 20.

PMID:
31362197
21.

High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.

Pfuderer PL, Ballhausen A, Seidler F, Stark HJ, Grabe N, Frayling IM, Ager A, von Knebel Doeberitz M, Kloor M, Ahadova A.

Br J Cancer. 2019 Aug;121(5):395-404. doi: 10.1038/s41416-019-0514-6. Epub 2019 Jul 30.

PMID:
31358939
22.

Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding site.

Watson ER, Grace CRR, Zhang W, Miller DJ, Davidson IF, Prabu JR, Yu S, Bolhuis DL, Kulko ET, Vollrath R, Haselbach D, Stark H, Peters JM, Brown NG, Sidhu SS, Schulman BA.

Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17280-17289. doi: 10.1073/pnas.1902889116. Epub 2019 Jul 26.

23.

Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis.

Sen A, Stark H.

World J Gastroenterol. 2019 Jun 21;25(23):2846-2862. doi: 10.3748/wjg.v25.i23.2846. Review.

24.

Novel meriolin derivatives as rapid apoptosis inducers.

Drießen D, Stuhldreier F, Frank A, Stark H, Wesselborg S, Stork B, Müller TJJ.

Bioorg Med Chem. 2019 Aug 1;27(15):3463-3468. doi: 10.1016/j.bmc.2019.06.029. Epub 2019 Jun 19.

PMID:
31248707
25.

Collective dynamics in a monolayer of squirmers confined to a boundary by gravity.

Kuhr JT, Rühle F, Stark H.

Soft Matter. 2019 Jul 17;15(28):5685-5694. doi: 10.1039/c9sm00889f.

PMID:
31246219
26.

Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands.

Schaller D, Hagenow S, Stark H, Wolber G.

PLoS One. 2019 Jun 25;14(6):e0218820. doi: 10.1371/journal.pone.0218820. eCollection 2019.

27.

Implementing a sustainable medication reconciliation process in Australian hospitals: The World Health Organization High 5s project.

Stark HE, Graudins LV, McGuire TM, Lee CYY, Duguid MJ.

Res Social Adm Pharm. 2019 May 23. pii: S1551-7411(18)30962-8. doi: 10.1016/j.sapharm.2019.05.011. [Epub ahead of print]

PMID:
31176651
28.

Nature-inspired pyrrolo[2,3-d]pyrimidines targeting the histamine H3 receptor.

Frank A, Meza-Arriagada F, Salas CO, Espinosa-Bustos C, Stark H.

Bioorg Med Chem. 2019 Jul 15;27(14):3194-3200. doi: 10.1016/j.bmc.2019.05.042. Epub 2019 May 29.

PMID:
31176569
29.

Chemotaxis in a binary mixture of active and passive particles.

Stürmer J, Seyrich M, Stark H.

J Chem Phys. 2019 Jun 7;150(21):214901. doi: 10.1063/1.5080543.

PMID:
31176313
30.

Structural and Functional Analyses of the Human PDH Complex Suggest a "Division-of-Labor" Mechanism by Local E1 and E3 Clusters.

Prajapati S, Haselbach D, Wittig S, Patel MS, Chari A, Schmidt C, Stark H, Tittmann K.

Structure. 2019 Jul 2;27(7):1124-1136.e4. doi: 10.1016/j.str.2019.04.009. Epub 2019 May 23.

PMID:
31130485
31.

Histamine H3 receptor antagonists/inverse agonists: Where do they go?

Ghamari N, Zarei O, Arias-Montaño JA, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M.

Pharmacol Ther. 2019 Aug;200:69-84. doi: 10.1016/j.pharmthera.2019.04.007. Epub 2019 Apr 24. Review.

PMID:
31028835
32.

Cognitive Improvements in Children with Prader-Willi Syndrome Following Pitolisant Treatment-Patient Reports.

Pullen LC, Picone M, Tan L, Johnston C, Stark H.

J Pediatr Pharmacol Ther. 2019 Mar-Apr;24(2):166-171. doi: 10.5863/1551-6776-24.2.166.

33.

Time-Resolved Measurements of Indoor Chemical Emissions, Deposition, and Reactions in a University Art Museum.

Pagonis D, Price DJ, Algrim LB, Day DA, Handschy AV, Stark H, Miller SL, de Gouw J, Jimenez JL, Ziemann PJ.

Environ Sci Technol. 2019 May 7;53(9):4794-4802. doi: 10.1021/acs.est.9b00276. Epub 2019 Apr 26.

PMID:
30990681
34.

Human β-Defensin 2 Expression in Oral Epithelium: Potential Therapeutic Targets in Oral Lichen Planus.

Salem A, Almahmoudi R, Hagström J, Stark H, Nordström D, Salo T, Eklund KK.

Int J Mol Sci. 2019 Apr 10;20(7). pii: E1780. doi: 10.3390/ijms20071780.

35.

Experimental autoimmune myocarditis in rats and therapeutic histamine H1 - H4 receptor inhibition.

Stasiak A, Gola J, Kraszewska K, Mussur M, Kobos J, Mazurek U, Stark H, Fogel WA.

J Physiol Pharmacol. 2018 Dec;69(6). doi: 10.26402/jpp.2018.6.13. Epub 2019 Mar 18.

36.

Investigation of the retention forces of secondary telescopic crowns made from Pekkton® ivory in combination with primary crowns made from four different dental alloys: an in vitro study.

Kotthaus M, Hasan I, Keilig L, Grüner M, Bourauel C, Stark H.

Biomed Tech (Berl). 2019 Sep 25;64(5):555-562. doi: 10.1515/bmt-2018-0167.

PMID:
30875315
37.

Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma.

Lanzi C, Lucarini L, Durante M, Sgambellone S, Pini A, Catarinicchia S, Łażewska D, Kieć-Kononowicz K, Stark H, Masini E.

Int J Mol Sci. 2019 Feb 24;20(4). pii: E981. doi: 10.3390/ijms20040981.

38.

Alkyl derivatives of 1,3,5-triazine as histamine H4 receptor ligands.

Łażewska D, Mogilski S, Hagenow S, Kuder K, Głuch-Lutwin M, Siwek A, Więcek M, Kaleta M, Seibel U, Buschauer A, Filipek B, Stark H, Kieć-Kononowicz K.

Bioorg Med Chem. 2019 Apr 1;27(7):1254-1262. doi: 10.1016/j.bmc.2019.02.020. Epub 2019 Feb 12.

PMID:
30792106
39.

Structural Insights into Nuclear pre-mRNA Splicing in Higher Eukaryotes.

Kastner B, Will CL, Stark H, Lührmann R.

Cold Spring Harb Perspect Biol. 2019 Nov 1;11(11). pii: a032417. doi: 10.1101/cshperspect.a032417. Review.

PMID:
30765414
40.

A flowing pair of particles in inertial microfluidics.

Schaaf C, Rühle F, Stark H.

Soft Matter. 2019 Feb 27;15(9):1988-1998. doi: 10.1039/c8sm02476f.

PMID:
30714602
41.

Ligand binding kinetics at histamine H3 receptors by fluorescence-polarization with real-time monitoring.

Reiner D, Stark H.

Eur J Pharmacol. 2019 Apr 5;848:112-120. doi: 10.1016/j.ejphar.2019.01.041. Epub 2019 Jan 28.

PMID:
30703360
42.

Comprehensive three-dimensional morphology of neoangiogenesis in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Neubert L, Borchert P, Shin HO, Linz F, Wagner WL, Warnecke G, Laenger F, Haverich A, Stark H, Hoeper MM, Kuehnel M, Ackermann M, Jonigk D.

J Pathol Clin Res. 2019 Apr;5(2):108-114. doi: 10.1002/cjp2.125. Epub 2019 Feb 27.

43.

One-megadalton metalloenzyme complex in Geobacter metallireducens involved in benzene ring reduction beyond the biological redox window.

Huwiler SG, Löffler C, Anselmann SEL, Stärk HJ, von Bergen M, Flechsler J, Rachel R, Boll M.

Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2259-2264. doi: 10.1073/pnas.1819636116. Epub 2019 Jan 23.

44.

Determining phoretic mobilities with Onsager's reciprocal relations: Electro- and thermophoresis revisited.

Burelbach J, Stark H.

Eur Phys J E Soft Matter. 2019 Jan 10;42(1):4. doi: 10.1140/epje/i2019-11769-y.

PMID:
30643995
45.

Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia.

Faisal M, Stark H, Büsche G, Schlue J, Teiken K, Kreipe HH, Lehmann U, Bartels S.

Cancer Med. 2019 Feb;8(2):742-750. doi: 10.1002/cam4.1946. Epub 2019 Jan 11.

46.

Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies.

Morris AP, Le TH, Wu H, Akbarov A, van der Most PJ, Hemani G, Smith GD, Mahajan A, Gaulton KJ, Nadkarni GN, Valladares-Salgado A, Wacher-Rodarte N, Mychaleckyj JC, Dueker ND, Guo X, Hai Y, Haessler J, Kamatani Y, Stilp AM, Zhu G, Cook JP, Ärnlöv J, Blanton SH, de Borst MH, Bottinger EP, Buchanan TA, Cechova S, Charchar FJ, Chu PL, Damman J, Eales J, Gharavi AG, Giedraitis V, Heath AC, Ipp E, Kiryluk K, Kramer HJ, Kubo M, Larsson A, Lindgren CM, Lu Y, Madden PAF, Montgomery GW, Papanicolaou GJ, Raffel LJ, Sacco RL, Sanchez E, Stark H, Sundstrom J, Taylor KD, Xiang AH, Zivkovic A, Lind L, Ingelsson E, Martin NG, Whitfield JB, Cai J, Laurie CC, Okada Y, Matsuda K, Kooperberg C, Chen YI, Rundek T, Rich SS, Loos RJF, Parra EJ, Cruz M, Rotter JI, Snieder H, Tomaszewski M, Humphreys BD, Franceschini N.

Nat Commun. 2019 Jan 3;10(1):29. doi: 10.1038/s41467-018-07867-7.

47.

Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects.

Ghamari N, Zarei O, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M.

Chem Biol Drug Des. 2019 May;93(5):832-843. doi: 10.1111/cbdd.13471. Epub 2019 Jan 24.

PMID:
30586225
48.

3.5  kW coherently combined ultrafast fiber laser.

Müller M, Klenke A, Steinkopff A, Stark H, Tünnermann A, Limpert J.

Opt Lett. 2018 Dec 15;43(24):6037-6040. doi: 10.1364/OL.43.006037.

PMID:
30547999
49.

Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield.

Thomson KL, Ormondroyd E, Harper AR, Dent T, McGuire K, Baksi J, Blair E, Brennan P, Buchan R, Bueser T, Campbell C, Carr-White G, Cook S, Daniels M, Deevi SVV, Goodship J, Hayesmoore JBG, Henderson A, Lamb T, Prasad S, Rayner-Matthews P, Robert L, Sneddon L, Stark H, Walsh R, Ware JS, Farrall M, Watkins HC; NIHR BioResource – Rare Diseases Consortium.

Genet Med. 2019 Jul;21(7):1576-1584. doi: 10.1038/s41436-018-0375-z. Epub 2018 Dec 11.

50.

Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell Division.

Watson ER, Brown NG, Peters JM, Stark H, Schulman BA.

Trends Cell Biol. 2019 Feb;29(2):117-134. doi: 10.1016/j.tcb.2018.09.007. Epub 2018 Oct 25. Review.

Supplemental Content

Support Center